[1]
Blauvelt, A., Paul, C., van de Kerkhof, P., Warren, R., Gottlieb, A., Langley, R., Brock, F., Arendt, C., Boehnlein, M., Lebwohl, M. and Reich, K. 2020. Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S5.